United Therapeutics (UTHR) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 02/26/25
United Therapeutics (UTHR) Surpasses Q4 Earnings and Revenue EstimatesZacks Investment Research • 02/26/25
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness Wire • 02/26/25
United Therapeutics: A Unique Business With High Margins And Expansion PotentialSeeking Alpha • 02/25/25
Seeking Clues to United Therapeutics (UTHR) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 02/24/25
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care ConferenceBusiness Wire • 02/24/25
United Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025Business Wire • 02/19/25
Strength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?Zacks Investment Research • 02/13/25
United Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary FibrosisBusiness Wire • 02/04/25
United Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical TrialBusiness Wire • 02/03/25
United Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual CongressBusiness Wire • 01/21/25
United Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceBusiness Wire • 01/06/25
Why Is United Therapeutics (UTHR) Up 1.1% Since Last Earnings Report?Zacks Investment Research • 11/29/24
United Therapeutics: Competitive Advantages At Such Cheap Multiples Scream BuySeeking Alpha • 11/15/24
United Therapeutics Expands Into Organ Transplants, But Tyvaso's Legal Battles LoomSeeking Alpha • 11/15/24
United Therapeutics Corporation to Present at the UBS Global Healthcare ConferenceBusiness Wire • 11/05/24
United Therapeutics (UTHR) is a Top-Ranked Growth Stock: Should You Buy?Zacks Investment Research • 11/05/24
United Therapeutics (UTHR) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 11/04/24